Cytogenetics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,300.00$ 8,900.00

Cytogenetic Market By Product (Consumables, Testing Kits, Media, and Reagents, Probes, Others (Affinity Reagents and Stains), Instruments, Software & Services), By Techniques (Comparative, Genomic Hybridization (CGH), Fluorescence in Situ Hybridization (FISH), Karyotyping, Immunohistochemistry, Others), By Application (Genetic Disorders, Cancer, Personalized Medicine, Others), By End User (Clinical & Research Laboratories, Pharmaceutical &, Biotechnology Companies, Academic Research Institutes, Others) and Geography

 

$ PRICE - $ 3,300.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,300.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Cytogenetics Market size is valued at USD 2.5 billion in 2021 and is poised to grow at a significant CAGR of 9.8% over 2022–2028. Bridging the gap between clinical applications of genetic results and offering an advanced medical service is the most crucial aim of human genetics. The adoption of cytogenetic techniques is directly impacted by the growth in the use of genetic information in predictive models for disease features, increasing income-generating. The market has been considerably pushed by rising cancer mortality rates and the associated increase in cancer incidence. The ongoing increase in cancer cases has highlighted the requirement for creating cutting-edge technology for a thorough understanding of cancer at the genomic level. Furthermore, the most well-known cytogenetic methods include FISH and CGH, which offer comprehensive details on the molecular signatures of cancer. These techniques help with gaining an understanding of how cancer develops. As several cytogenetic procedures have been effectively used for pharmacogenomic biomarker investigations, expanding pharmacogenomics activities are predicted to impact market growth significantly. A sizable number of published studies proving the function of cytogenetic methods in pharmacogenomic testing demonstrate the practical application of CGH, FISH, and sequencing technology in pharmacogenomics. The application range of cytogenetics techniques has been expanded due to ongoing improvements in CGH and FISH regarding resolution and specificity in basic research and molecular diagnostics. These developments have effectively overcome the limits of traditional cytogenetic analysis. Moreover, it is anticipated that the worldwide cytogenetics market will expand in the upcoming years due to an increase in health care spending, the prevalence of chronic diseases, and a favorable reimbursement environment. Additionally, market players use cutting-edge methods and tactics to develop original approaches to cytogenetic analysis, which is predicted to drive the market. However, emerging markets are anticipated to offer the industry excellent market possibilities during the projection period.

Recent Market Developments:

In March 2020, Agilent Technologies Inc. launched three new microarrays to meet the requirement of cytogenetics laboratories that conduct prenatal and postnatal research.

Cytogenetics Market

MARKET SUMMARY
-
9.8% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 9.8%
  • Largest Market– Europe
  • Fastest Growing Market– North America

Cytogenetics Market

  • The global cytogenetics market report gives comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global cytogenetics market gives historical, current, and future market sizes (US$ Mn) on the basis of product, techniques, application, end user and Region.
Key Players
  • Agilent Technologies
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories
  • Oxford Gene Technology
  • Applied Spectral Imaging
Cytogenetics Market Dynamics

As cancer cases increase, different molecular cytogenetics techniques are increasingly employed for diagnosis. Aside from that, the cytogenetics sector’s development is fueled by the expansion of cancer research because cutting-edge methods are required to comprehend cancer at the chromosomal level. For instance, FISH and CGH procedures offer vital information on cancer-related molecular markers, leading to market development. FISH, chromosomal image analysis, flow sorting, and in-situ genomic hybridization (GISH), created to synthesize synthetic plant chromosomes, are used to develop genetic, physical, molecular, and comparative maps. However, the high price of cytogenetic tools restricts commercial expansion.


North-America Got Significant Share

Cytogenetics Market

The Cytogenetic market in North America is likely to hold a significant revenue share in 2022, and, in the following years, it is predicted to increase rapidly. This is due to the widespread use of technologically advanced products, several manufacturers in the U.S., and the high cost of healthcare in the area. Asia-Pacific and Latin America are anticipated to be lucrative regions of the cytogenetics market due to the growth of the economies in these regions, the rising population, the rise in the incidence of cancer, and the increased awareness and adoption of cytogenetic analysis among the populace. Additionally, Asia is a sizable continent that has become the center of a significant portion of the world's population.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The cytogenetic market report provides granular level information about the market size, regional market share, historic market (2016-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Cytogenetics Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The cytogenetic market is projected to expand at a CAGR of 9.8% during the forecast period.

Agilent Technologies, PerkinElmer, Inc., Illumina, Inc., Bio-Rad Laboratories, Oxford Gene Technology, Applied Spectral Imaging

North America is the fastest-growing region for cytogenetic market


Report

Company Profile

  • Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories,
  • Agilent Technologies
  • PerkinElmer, Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories
  • Oxford Gene Technology
  • Applied Spectral Imaging

Description

Cytogenetics Market size is valued at USD 2.5 billion in 2021 and is poised to grow at a significant CAGR of 9.8% over 2022–2028. Bridging the gap between clinical applications of genetic results and offering an advanced medical service is the most crucial aim of human genetics. The adoption of cytogenetic techniques is directly impacted by the growth in the use of genetic information in predictive models for disease features, increasing income-generating. The market has been considerably pushed by rising cancer mortality rates and the associated increase in cancer incidence. The ongoing increase in cancer cases has highlighted the requirement for creating cutting-edge technology for a thorough understanding of cancer at the genomic level. Furthermore, the most well-known cytogenetic methods include FISH and CGH, which offer comprehensive details on the molecular signatures of cancer. These techniques help with gaining an understanding of how cancer develops. As several cytogenetic procedures have been effectively used for pharmacogenomic biomarker investigations, expanding pharmacogenomics activities are predicted to impact market growth significantly. A sizable number of published studies proving the function of cytogenetic methods in pharmacogenomic testing demonstrate the practical application of CGH, FISH, and sequencing technology in pharmacogenomics. The application range of cytogenetics techniques has been expanded due to ongoing improvements in CGH and FISH regarding resolution and specificity in basic research and molecular diagnostics. These developments have effectively overcome the limits of traditional cytogenetic analysis. Moreover, it is anticipated that the worldwide cytogenetics market will expand in the upcoming years due to an increase in health care spending, the prevalence of chronic diseases, and a favorable reimbursement environment. Additionally, market players use cutting-edge methods and tactics to develop original approaches to cytogenetic analysis, which is predicted to drive the market. However, emerging markets are anticipated to offer the industry excellent market possibilities during the projection period.

Recent Market Developments:

In March 2020, Agilent Technologies Inc. launched three new microarrays to meet the requirement of cytogenetics laboratories that conduct prenatal and postnatal research.

Reviews

There are no reviews yet.

Be the first to review “Cytogenetics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX